According to the charges, Catenacci served as one of the lead physicians and primary field investigators on a clinical trial by a California-based biotechnology company, identified only as Company A. Through this position, Catenacci allegedly received confidential information about the company and its clinical trial results.
Feds: Top U. of C. doctor used insider knowledge of cancer drug to make stock market windfall – Chicago Tribune
